Shares of Kura Oncology Inc. (NASDAQ:KURA) dropped 5.8% during mid-day trading on Tuesday . The stock traded as low as $4.05 and last traded at $4.06, with a volume of 50,665 shares traded. The stock had previously closed at $4.31.

A number of brokerages have weighed in on KURA. Oppenheimer Holdings Inc. restated an “outperform” rating and issued a $16.00 target price on shares of Kura Oncology in a research report on Tuesday, June 21st. Zacks Investment Research lowered shares of Kura Oncology from a “buy” rating to a “hold” rating in a research report on Tuesday, May 17th.

The company’s market cap is $73.76 million. The firm’s 50 day moving average price is $3.45 and its 200 day moving average price is $3.66.

Kura Oncology (NASDAQ:KURA) last posted its quarterly earnings results on Wednesday, May 11th. The company reported ($0.36) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.35) by $0.01. Equities research analysts expect that Kura Oncology Inc. will post ($1.70) EPS for the current fiscal year.

Kura Oncology, Inc is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing personalized therapeutics for the treatment of solid tumors and blood cancers. Its segment is engaged in the discovery and development of personalized therapeutics for the treatment of solid tumors and blood cancers.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.